Acceleration Point released the study, Exploring Rare Disease Landscape Using Social Media Listening to Assess Patient Voices, this week at ISPOR 2024 in Atlanta, Georgia.
The new study leveraged social media listening to provide insights on the patient journey for Cushing’s Syndrome (CS), including a focus on unmet concerns like quality of life, support from HCP’s and peers, delayed diagnosis, missed diagnosis and caregiver support.
“As a company dedicated to revolutionizing insight generation for medical affairs teams, I am immensely proud of our team’s unwavering commitment to empowering our customers with valuable patient insights”, said Acceleration Point SVP Jeff Buchanan. “Historically, obtaining real-world, patient-focused insights has been both time-consuming and challenging, yet it remains crucial. By harnessing social media data, we enable our customers to better understand patients’ challenges in diagnosis, treatment, and overall quality of life. Demonstrating this capability in diseases like Cushing’s Syndrome provides access to insights where published patient data falls short.”
About Acceleration Point
Acceleration Point is a leading provider of insight solutions and services for Medical Affairs teams. Our mission is to help Medical Affairs teams learn from top KOLs around the world. We are committed to revolutionizing the process of gathering, analyzing, and leveraging insights within the pharmaceutical industry, ensuring that every piece of information serves to advance patient care and organizational success. Acceleration Point is a global company with offices in Roanoke, Virginia and London, United Kingdom.
For more information, please visit www.accelerationpoint.com.
